The Living Guidelines: Drug Eluting and Bare Metal Stents Polling Results for CLASS I Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class I Guidelines
1. A DES should be considered as an alternative to a BMS in those patients for whom clinical trials indicate a favorable effectiveness/safety profile. (Class I Level of Evidence: A)

 AHA / ACC 2007 PCI Guidelines Class I Recommendation 1 for Drug Eluting and Bare Metal Stents should be CLASS I CLASS IIa CLASS IIb CLASS III

2. Before implanting a DES, the interventional cardiologist should discuss with the patient the need for and duration of dual antiplatelet therapy and confirm the patient’s ability to comply with the recommended therapy for DES. (Class I Level of Evidence: B)

 AHA / ACC 2007 PCI Guidelines Class I Recommendation 2 for Drug Eluting and Bare Metal Stents should be CLASS I CLASS IIa CLASS IIb CLASS III

3. In patients who are undergoing preparation for PCI and are likely to require invasive or surgical procedures for which dual antiplatelet therapy must be interrupted during the next 12 months, consideration should be given to implantation of a BMS or performance of balloon angioplasty with a provisional stent implantation instead of the routine use of a DES. (Class I Level of Evidence: C)

 AHA / ACC 2007 PCI Guidelines Class I Recommendation 3 for Drug Eluting and Bare Metal Stents should be CLASS I CLASS IIa CLASS IIb CLASS III